NCT00253175 – A Comparison Of The Efficacy And Safety Of Topamax® (Topiramate) Tablets Versus Placebo For The Prophylaxis Of Migraine Posted on March 26, 2020 by tsuperadmin -
NCT00210496 – Efficacy of AXERT (Almotriptan Malate) in the Acute Treatment of Migraine: A Pilot Study of the Potential Impact of Preventive Therapy With TOPAMAX (Topiramate) Posted on February 5, 2020 by tsuperadmin -
NCT00210821 – A Comparison of Topiramate Versus Amitriptyline in Migraine Prophylaxis Posted on February 5, 2020 by tsuperadmin -
NCT00237302 – A Comparison of the Efficacy and Safety of Topiramate Versus Placebo for the Prophylaxis of Migraine in Pediatric Subjects Posted on July 3, 2019 by tsuperadmin -
NCT00216619 – A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Investigate the Efficacy and Tolerability of Topiramate in Prolonged Migraine Prevention Posted on November 22, 2017 by tsuperadmin -
NCT00210912 – A Comparison of the Efficacy and Safety of Topiramate Versus Placebo for the Prophylaxis of Chronic Migraine Posted on November 10, 2014 by tsuperadmin -
NCT00212810 – TOPAMAX (Topiramate) Intervention to Prevent Transformation of Episodic Migraine: The Topiramate INTREPID Study Posted on November 10, 2014 by tsuperadmin -
NCT00216606 – A Randomized Double-Blind Placebo Controlled Trial to Investigate the Efficacy and Tolerability of Topiramate in the Prophylaxis of Chronic Migraine Posted on November 10, 2014 by tsuperadmin -
NCT00236561 – A Randomized, Double-Blind, Parallel-Group, Dose-Response Study to Evaluate the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prophylaxis of Migraine Posted on November 10, 2014 by tsuperadmin -
NCT00231595 – A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of Topiramate in the Prophylaxis of Migraine Posted on November 10, 2014 by tsuperadmin -
The YODA Project